• HTA366 NICE Technology Appraisals Based on Single-Arm Trials in 2022 – What Can We Learn from Them?

    Dec 1, 2023, 00:00

  • EE278 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United Kingdom

    Dec 1, 2023, 00:00

  • EE624 The Economic Burden of Macrovascular Complications of Diabetes in Algeria

    Dec 1, 2023, 00:00

  • CO109 A Targeted Review of Pharmacological Therapies for the Treatment of Chronic Spontaneous Urticaria

    Dec 1, 2023, 00:00

  • CO45 A Systematic Review of Quality of Life and Gastroesophageal Reflux Disease

    Dec 1, 2023, 00:00

  • HTA121 The Triple Bottom Line in Healthcare: A Holistic Sustainability Assessment for Decision Support

    Dec 1, 2023, 00:00

  • EE424 Cost-Utility and Budget Impact Analyses of Tumor Necrosis Factor Inhibitor Biologics and Biosimilars Versus Rituximab in Thai Patients with Active Rheumatoid Arthritis

    Dec 1, 2023, 00:00

  • SA71 Real-World Treatment Patterns for Acute Lymphoblastic Leukemia Utilizing Claims Data

    Dec 1, 2023, 00:00

  • EE607 Development of an Online Database of Published Usable Mapping Algorithms Used to Estimate EQ-5D Utilities

    Dec 1, 2023, 00:00

  • RWD19 Risk of Death Before and After Metastasis in High-Risk Localized and Locally Advanced Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy as Primary Treatment in the United States: A Retrospective Study

    Dec 1, 2023, 00:00

  • MT70 Robotic-Assisted Surgery Versus Open Surgery in Endometrial Cancer: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • HTA37 Assessing the Definition and Outcomes of Innovative Drugs by Health Technology Assessment Bodies in England, France, and Italy (Q1 2023)

    Dec 1, 2023, 00:00

  • HSD109 What Are the Main Challenges in Management Care of Stoma Patients in Fran Guidelines from Shield Multidisciplinary Experts for Optimization

    Dec 1, 2023, 00:00

  • RWD28 Healthcare Resource Utilization and Cost of Renal Replacement Therapy in Brazil: A Five-Year Patient-Level Analysis

    Dec 1, 2023, 00:00

  • EE469 Diabetic Retinopathy in Algeria: Costs Estimation and Medical-Economic Value of Automated Methods AI-Based in Early Screening

    Dec 1, 2023, 00:00

  • MSR118 Identifying Potential Long-COVID Patients Using Machine Learning: A German Claims Data Analysis

    Dec 1, 2023, 00:00

  • HPR71 All Back to Square One: What Follows from the New Algorithm for Drug Pricing in Germany?

    Dec 1, 2023, 00:00

  • P10 Impact of the COVID-19 Pandemic on Cancer Screenings in Portugal and Years of Life Lost Due to Delayed Diagnoses

    Dec 1, 2023, 00:00

  • PT48 International Reference Pricing Analysis of Medicines in Turkiye By 2022

    Dec 1, 2023, 00:00

  • EE635 Medical Cost Trends for Diseases Associated with Bedridden Rural Residents in Japan

    Dec 1, 2023, 00:00

  • HPR219 "Direct Access" Experiment in Fran Potential Impact on the Pricing of Innovative Medicines

    Dec 1, 2023, 00:00

  • HSD58 Real-World Prescribing of Long-Acting Injectable Cabotegravir for Treatment of HIV in the United States

    Dec 1, 2023, 00:00

  • EE416 The Cost-Effectiveness of WaveWriter Alpha Spinal Cord Stimulation System in a Swedish Setting

    Dec 1, 2023, 00:00

  • PCR88 Use of Patient-Reported Outcomes for Sickle-Cell Disease in Clinical Trials – Do They Match with Consensus-Based Core Outcomes Sets Recommendations?

    Dec 1, 2023, 00:00

  • PCR115 Health-Related Quality of Life Associated With Common Stoma Complications—Peristomal Skin Complications and Leakages Onto Clothes

    Dec 1, 2023, 00:00

  • EPH126 Gender-Affirming Hormone Therapy and Psychological Distress Among Transgender and Nonbinary People: Differences by Source of Hormones

    Dec 1, 2023, 00:00

  • MSR64 How Is Machine Learning Being Used in HEOR? A Systematic Review of Trends and Methods

    Dec 1, 2023, 00:00

  • EE223 Estimation of the T-Cell Engagers (Bi-Specific Monoclonal Antibodies and Chimeric Antigen Receptor [CAR T-CELL]) Therapy Administration Pathways From French Hospitals and National Health Insurance Perspective and Financial Impact

    Dec 1, 2023, 00:00

  • EE588 The Budget Impact of Introducing Robotic-Assisted Surgery for Spinal Fusion Procedures in Spain

    Dec 1, 2023, 00:00

  • PT14 Bayesian Meta-Analysis of Data From Trials of Mixed Patient Populations to Inform Health Economic Models for Patients Harboring a Predictive Biomarker

    Dec 1, 2023, 00:00

  • EE258 Healthcare Resource Utilization and Economic Burden of Hidradenitis Suppurativa in German Patients with Hidradenitis Suppurativa

    Dec 1, 2023, 00:00

  • HTA292 Implications of EU HTA on Future Relevance of Surrogate Outcomes in National Assessment

    Dec 1, 2023, 00:00

  • MT3 Intracardiac Echocardiography Operational Experience of Chinese Interventional Cardiologists in Conducting Radio-Frequency Catheter Ablation for Cardiac Arrhythmias: A Cross-Sectional Survey Study

    Dec 1, 2023, 00:00

  • EE175 Cost-Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada

    Dec 1, 2023, 00:00

  • MSR84 Summarizing Adverse Event Data in the Absence of High-Level Eviden The Case of Hearing Implants

    Dec 1, 2023, 00:00

  • EE190 How Many Patients Diagnosed with Mild Cognitive Impairment Are Willing to Pay for a PET Scan to Receive the Treatment for Alzheimer′S Disease in Japan?

    Dec 1, 2023, 00:00

  • MSR42 A Parametric Method for Unanchored Matching-Adjusted Indirect Treatment Comparison (MAIC) Based on Survival Outcomes for Health Economic (HE) Models in Absence of Proportional Hazards (PH)

    Dec 1, 2023, 00:00

  • PT43 Cost-Effectiveness Analysis of Prostate-Specific Antigen (PSA)-Based Risk-Adapted Screening in Germany: An Early Economic Evaluation Study

    Dec 1, 2023, 00:00

  • CO144 A Trial-Based Health Utility Analysis in Patients with Acanthamoeba Keratitis

    Dec 1, 2023, 00:00

  • MSR92 Can Artificial Intelligence (AI) Large Language Models (LLMS) Such as Generative Pre-Trained Transformer (GPT) Be Used to Automate Literature Reviews?

    Dec 1, 2023, 00:00

  • MT28 Physician Experiences and Preferences in Peripheral Bronchoscopy for Diagnosing Patients with Solitary Pulmonary Nodules Suspected of Lung Cancer: A Multi-Country, Cross-Sectional Survey

    Dec 1, 2023, 00:00

  • HTA5 An Evaluation of the NICE Early Value Assessment: What Is the Opportunity for Digital Therapeutics?

    Dec 1, 2023, 00:00

  • HTA207 Can We Speak to GPT to Inform Health Technology Assessments?

    Dec 1, 2023, 00:00

  • PCR274 Patient Data Use in Medical Research Vs Data Privacy: Perspective from Five Patient Association Representatives

    Dec 1, 2023, 00:00

  • HSD117 Healthcare Resources Utilization (HCRU) and Exploration of the Patient Journey through Claims Database: An Application on Advanced Renal Cell Carcinoma (ARCC) Patients in France

    Dec 1, 2023, 00:00

  • HSD81 Automated Report Generation with Chat GPT API for Cardiology: Performance Evaluation and Impact on Physician Burnout

    Dec 1, 2023, 00:00

  • EE283 Value of Information Analyses for Advanced Cell Therapies: A Systematic Review

    Dec 1, 2023, 00:00

  • EE311 Starts with Sacubitril/Valsartan in the Inpatient Vs Outpatient Setting in Spain

    Dec 1, 2023, 00:00

  • EE615 A Cost-Effectiveness Analysis of the CNIC-Polypill Strategy, Compared to Usual Care, in Secondary Cardiovascular Prevention from a Spanish Perspective Using Data from the Secure Trial

    Dec 1, 2023, 00:00

  • EE435 Cost-Analysis of a Machine Learning-Based Clinical Decision Support System to Guide Resilience-Strengthening Intervention Decisions in Breast Cancer Treatment: The Bounce Study

    Dec 1, 2023, 00:00

  • HTA136 Analysis of the Reimbursement and Pricing of Hybrid Medicines in France

    Dec 1, 2023, 00:00

  • HTA145 Similarity of Guidelines for Direct and Indirect Comparisons Under Eunethta and Country-Specific HTA – Implications for Supportive Agents

    Dec 1, 2023, 00:00

  • HPR63 Plasma Last Liter Economics and Its Impact on the Costs of Major Human Polyvalent Immunoglobulins in Europe

    Dec 1, 2023, 00:00

  • EE228 Cost to Society and Financial Toxicity Related to Personalized Oncology Treatment in Bulgaria

    Dec 1, 2023, 00:00

  • CO26 Efficacy of the Dupilumab 200 Mg Dose Every 2 Weeks in Children with Moderate-to-Severe Asthma during Voyage and Excursion

    Dec 1, 2023, 00:00

  • HPR116 Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation

    Dec 1, 2023, 00:00

  • EE655 Patients Level Cost of Treating Adverse Events in Alzheimer’s Disease for US-FDA Approved Treatments

    Dec 1, 2023, 00:00

  • EPH117 The Phollow Cohort: Real-World Therapeutic Adherence to Blood Glucose-Lowering Drugs (EXCLUDING INSULINS) in Portugal

    Dec 1, 2023, 00:00

  • HPR33 Follow the Money: Reporting Public Contributions and Incentives on Research and Development Programs for Agenzia Italiana Del Farmaco (AIFA; ITALIAN MEDICINES AGENCY)

    Dec 1, 2023, 00:00

  • SA6 Cost-of-Illness of Skin Cancer: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE116 Quantifying the Future Impact of Chronic Kidney Disease Screening Programs in Belgium

    Dec 1, 2023, 00:00

  • PT12 Perceived Financial Burden and Quality of Life Among Patients with Cancer

    Dec 1, 2023, 00:00

  • OP21 A Validated Dutch Translation of the CHEERS II Statement

    Dec 1, 2023, 00:00

  • HSD113 Access to Medicines, Care, and Services for Multiple Sclerosis Patients in Central and Eastern European Countries: A Comparative Analysis

    Dec 1, 2023, 00:00

  • HTA267 Is the BBC Truly Impartial When Reporting on NICE’s Activities?

    Dec 1, 2023, 00:00

  • PCR236 Treatment Preferences Among Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in France, Germany, Italy, Japan, Spain, the United States, and the United Kingdom

    Dec 1, 2023, 00:00

  • EPH94 Comparative Analysis of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus: A Nationwide US Medicare Perspective

    Dec 1, 2023, 00:00

  • HSD12 Hepatocellular Carcinoma Patient Pathway in Portugal – From Diagnosis to Treatment – Results From Opal Study

    Dec 1, 2023, 00:00

  • HTA281 Environmental Considerations in HTA: Can HTA Bodies Contribute to Environmental Sustainability?

    Dec 1, 2023, 00:00

  • EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer

    Dec 1, 2023, 00:00

  • HSD49 Impact of Endoscope Choice on Nurse Time in GI Surgical Procedures: A Prospective Study in a Danish University Hospital

    Dec 1, 2023, 00:00

  • EPH11 Prevalence, Risk Factors, and Characterization of Individuals with Long COVID Using Electronic Health Records in Over 1.5 Million COVID Cases in England

    Dec 1, 2023, 00:00

  • EPH200 Healthcare Resource Consumption of Patients with Chronic Obstructive Pulmonary Disease Treated with Triple and Dual Therapy and Experiencing an Acute Exacerbation

    Dec 1, 2023, 00:00

  • RWD104 Shifting Tides: Unveiling the Burden of Demographic Change in Germany Through Administrative Hospital Data

    Dec 1, 2023, 00:00

  • PCR222 Safety and Quality of Life of Various Artificial Pancreas Systems in Patients With Type 1 Diabetes Mellitus: A Systematic Review of Real-World Evidence

    Dec 1, 2023, 00:00

  • EPH54 What Do the Students Think About Food Safety Knowledge at the University of Pécs?

    Dec 1, 2023, 00:00

  • EE263 Economic and Healthcare Burden of Blood Transfusions in Transfusion-Dependent Beta-Thalassemia in Thailand and Brazil

    Dec 1, 2023, 00:00

  • PT41 Real-World Evidence in Rare Diseases in Fran Treatment Patterns, Healthcare Resource Use, and Related Costs in Von Willebrand Disease (FORvWARD Study)

    Dec 1, 2023, 00:00

  • SA65 Trends in the Systematic Literature Reviews Over the Years

    Dec 1, 2023, 00:00

  • EE237 The Budget Impact of Introducing Automated Hematoxylin and Eosin Staining for Cancer Diagnosis in China

    Dec 1, 2023, 00:00

  • HTA91 5 Years of CAR-T Cell Therapies—Comparison of German AMNOG Dossiers in Terms of Available Evidence and Price Development

    Dec 1, 2023, 00:00

  • EE358 A Systematic Literature Review of Reviews Related to the Impacts of Catastrophic Health Expenditures Related to Cancer Care

    Dec 1, 2023, 00:00

  • PCR159 Considerations for Maximizing the Research Value of PRO Data Collected in Clinical Care

    Dec 1, 2023, 00:00

  • SA57 Unmet Needs and Evidence Gaps in Relapsed/Refractory Marginal Zone Lymphoma: Findings from a Systematic Literature Review

    Dec 1, 2023, 00:00

  • MSR56 Incorporating Background Mortality Into Survival Extrapolations: Determining the Accuracy Using a Simulation Study

    Dec 1, 2023, 00:00

  • EE154 Cost-Effectiveness of Transcatheter Aortic Valve Intervention (TAVI) as Compared with Surgical Aortic Valve Intervention (SAVR) in Swedish Low Risk Aortic Stenosis Patients: Evidence Using Swedeheart Registry Data (2018-2020)

    Dec 1, 2023, 00:00

  • PCR110 Translation and Cultural Adaptation of Clinical Outcome Assessments (COAs)—Is Machine Translation a Viable Option?

    Dec 1, 2023, 00:00

  • EE433 Cost and Duration of Hospital Stays for Complex Patients Receiving a Micra or a Conventional Pacemaker With Epicardial Leads in France

    Dec 1, 2023, 00:00

  • HTA347 Exploration of the Factors Driving Decisions of the Transparency Commission Based on an Analysis of HAS Meeting Transcripts Using Natural Language Processing

    Dec 1, 2023, 00:00

  • EE344 Cost per Responder Associated with Bimekizumab Against Il-17A-Inhibitors in the Treatment of Axial Spondyloarthritis in Sweden

    Dec 1, 2023, 00:00

  • EE222 Cost Minimization Analysis of Damoctocog Alfa Pegol in the Treatment of Severe Hemophilia A Patients in Mexico

    Dec 1, 2023, 00:00

  • HTA284 Early Access in Fran Descriptive Analysis of Eap Decisions Two Years after the Reform

    Dec 1, 2023, 00:00

  • Section 50 of the Inflation Reduction Act Drug Price Negotiation Program: Considerations for the Centers for Medicare Medicaid Services, Manufacturers, and the Health Economics and Outcomes Research Community [Editor's Choice]

    Dec 1, 2023, 00:00

  • PCR114 The Association Between Health-Related Quality of Life and Social Determinants of Health for Diabetes in Japan: A Cross-Sectional Patient Survey

    Dec 1, 2023, 00:00

  • EPH227 Clinical, Economic, and Patient-Reported Impact of Obesity in Selected European Countries: A Systematic Review

    Dec 1, 2023, 00:00

  • HSD61 The Diagnostic Journey of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia, and the Importance of Biomarker Testing for Timely Diagnosis: A Real-World Survey in Europe

    Dec 1, 2023, 00:00

  • HSD112 Real-World Trends in APOE Genetic Testing Associated with Lecanemab

    Dec 1, 2023, 00:00

  • EE187 Use of Resources and Economic Cost of People Living with HIV in the Brazilian Supplementary Health System

    Dec 1, 2023, 00:00

  • EE593 Cost-Effectiveness Model of COVID-19 Vaccination: The United Kingdom Perspective

    Dec 1, 2023, 00:00

  • CO69 Evidence Gap Analysis of the Burden of Illness and Treatment of Bullous Pemphigoid

    Dec 1, 2023, 00:00

  • RWD40 Assessing the Representativeness of Body Mass Index Categories Across Multiple Types of Secondary Data Sources

    Dec 1, 2023, 00:00

  • SA41 Novel Method for Indirect Comparison of Treatment Sequences Using Averaged Parametric Survival Models with Application to Hepatocellular Carcinoma

    Dec 1, 2023, 00:00

  • HTA108 Willingness-to-Pay for Orphan Drugs – ICER Thresholds Approved by TLV in Sweden

    Dec 1, 2023, 00:00

  • HTA22 Access to Orphan Pediatric and Adolescent Medicinal Products in Greece Over 4 Years (2018-2021)

    Dec 1, 2023, 00:00

  • HTA107 Are All Unmet Needs Valued the Same? A Review of Disease Prioritization and Related Resource Allocation in Europe

    Dec 1, 2023, 00:00

  • EE149 Surge Capacity for Preserving Accessibility to Primary Healthcare Services during the COVID19 Pandemic in a Middle Income Country

    Dec 1, 2023, 00:00

  • CO43 Projecting Cardiovascular Benefits Associated With Tirzepatide's Effects on Cardiovascular Risk Factors in Patients With Type 2 Diabetes in Fran A Simulation Study

    Dec 1, 2023, 00:00

  • PCR117 A Qualitative Interview Study into the Experiences of Fatigue and Depression in Chronic Hepatitis B

    Dec 1, 2023, 00:00

  • EE339 Use of Dalbavancin in the Treatment of Pediatric Acute Bacterial Skin and Skin Structure Infections in the Spanish Hospital Setting: A Comparative Cost Analysis

    Dec 1, 2023, 00:00

  • HSD118 Patient Safety in Oncology: Quantifying the Hospital-Associated Risks with a Discrete-Events Simulation

    Dec 1, 2023, 00:00

  • MT67 The Effectiveness of Body Composition Analysis Using Dual-Energy X-Ray Absorptiometry (DEXA) for Diagnosing Sarcopenia: Literature Review

    Dec 1, 2023, 00:00

  • EE85 Health System Costs and Resources for Stage-Specific Breast Cancer: A Population-Based Approach (Updated)

    Dec 1, 2023, 00:00

  • HPR3 Burden of HIV/AIDS Assessment and Forecast for 2030 in Turkiye

    Dec 1, 2023, 00:00

  • EE407 Economic Assessment in Resource-Constrained Systems – a Case Study Using an Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema

    Dec 1, 2023, 00:00

  • HTA166 Cost-Effectiveness of Combination Pertuzumab+Trastuzumab Vs Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer (HER2+ eBC) in the Czech Republic

    Dec 1, 2023, 00:00

  • EPH179 Ibuprofen, Other Nsaids, COVID-19: A Narrative Review

    Dec 1, 2023, 00:00

  • PT20 Applications for Tolvaptan (JINARC®) Under a Managed Access Protocol in Ireland

    Dec 1, 2023, 00:00

  • HPR66 Assessing the Impact and Strategic Implications of the HTA Regulation 2021/20282 on National Processes: A Scoping Review and Stakeholders Perspectives Through Semi-Structured Interviews

    Dec 1, 2023, 00:00

  • EE210 Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy as Neoadjuvant Therapy and Continued as a Single Agent as Adjuvant Therapy for High-Risk Early-Stage Triple-Negative Breast Cancer in Greece

    Dec 1, 2023, 00:00

  • EE471 Investigating the Impact of Pseudo-Random Numbers Generator on a Probabilistic Sensitive Analysis (PSA) Results

    Dec 1, 2023, 00:00

  • RWD180 Analyzing Medical Patterns and Catastrophic Health Expenses in Occupational Injuries Victims in South Korea

    Dec 1, 2023, 00:00

  • EE130 Impact of Phacoemulsification Equipment in Surgical Throughput, Under the Perspective of a Greek Hospital

    Dec 1, 2023, 00:00

  • EE589 Use of Copulas for Correlated Sampling of Cost and Utility Parameters During Probabilistic Sensitivity Analysis for Cost-Effectiveness Analyses

    Dec 1, 2023, 00:00

  • PT42 The Impact of Spinal Muscular Atrophy Type 2 on Caregivers in Argentina: Results of a Global Survey

    Dec 1, 2023, 00:00

  • EE747 Cost-Utility Analysis of 15-Valent Pneumococcal Conjugate Vaccine in the Immunization of Adults Over 65 Years of Age in the Czech Republic

    Dec 1, 2023, 00:00

  • EE510 Downstaging Pancreatic Cancer is Cost-Effective: Can We Achieve a Cost-Effective Early Diagnosis?

    Dec 1, 2023, 00:00

  • EPH18 Incidence of Postpartum Mental and Behavioral Disorders in Japan

    Dec 1, 2023, 00:00

  • HTA87 Mapping Accumulating Evidence Across Multiple Indications in Oncology Health Technology Assessment

    Dec 1, 2023, 00:00

  • HTA294 Using Machine Learning to Predict HTA Approval: Importance of Patient Subgroup Specification Within Obesity

    Dec 1, 2023, 00:00

  • EPH12 Estimating the Prevalence of Hepatitis Delta in the UK: A Migration Model Approach Applied in Practice

    Dec 1, 2023, 00:00

  • P39 Machine Learning to Identify Atopic Dermatitis Prevalence Using Healthcare Utilisation Patterns of Both Diagnosed and Non-Diagnosed AD Patients Based on Danish Register Data

    Dec 1, 2023, 00:00

  • PCR227 Do Family Spillover Effects of Illness Vary With the Age of the Ill Individual?

    Dec 1, 2023, 00:00

  • PCR206 Characterization of the Lupus Patient Experience Based on Longitudinal Patient Generated Real World Data from a Digital Health App (HEALTH STORYLINES)

    Dec 1, 2023, 00:00

  • HSD18 Itch Intensity and Therapeutic Management of Pruritus in the Real-World Setting

    Dec 1, 2023, 00:00

  • HTA81 Exploring the Gap Between Regulatory Labels and Reimbursed Indications of Oncology Drugs in the Netherlands

    Dec 1, 2023, 00:00

  • EE591 Impact of Flu Vaccine Shortage on the National Health Service (NHS) in England and Wales

    Dec 1, 2023, 00:00

  • EE167 Budget Impact Analysis of Sensor Augmented Pump Therapy for Type 1 Diabetes (T1D) in Bulgaria

    Dec 1, 2023, 00:00

  • HSD73 Establishing a Learning Healthcare System for Metastatic Prostate Cancer in the Dutch Healthcare System: Preconditions and Potential Benefits of Real-World Data Utilization

    Dec 1, 2023, 00:00

  • EPH114 Clinical Characteristics, Average Cost Per Visit, and Major Adverse Cardiovascular Events in Patients with Diagnosed Chronic Kidney Disease Combined with Cardiovascular Disease: A Study from a Large Healthcare Database in China

    Dec 1, 2023, 00:00

  • MSR15 The Impact of Response Assessment Timing on Indirect Treatment Comparisons (ITCS) – A Simulation Study

    Dec 1, 2023, 00:00

  • HTA340 Is There Equity of Access to Highly Specialized Treatments Between England and Northern Ireland?

    Dec 1, 2023, 00:00

  • HTA226 Can Prior Indirect Treatment Comparisons (ITCs) Inform Health Technology Assessment (HTA) Strategy: A Case Study in Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL)

    Dec 1, 2023, 00:00

  • EE157 The Societal Impact of Inclisiran Using Population Health Approaches Across 15 Countries

    Dec 1, 2023, 00:00

  • HTA25 What Is a Highly Specialised Technology (HST)? The Revised NICE HST Criteria in Practice

    Dec 1, 2023, 00:00

  • RWD52 A Machine Learning Model to Facilitate Patient-Level Risk Screening in Myelodysplastic Syndromes (MDS) Patients in Routine Clinical Practice

    Dec 1, 2023, 00:00

  • HSD45 Atopic Dermatitis’ Treatment Patterns in Latin America: A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE252 The Economic Implication of Sinus Rapid Relief Pathway in Italy: Awake Surgery Vs General Anesthesia to Guarantee Quick Access to Patients Who Needs Sinus Surgery

    Dec 1, 2023, 00:00

  • RWD68 How Pharmaceutical, Biotechnology and Medical Technology Companies Use Clinical Practice Research Datalink (CPRD) Data: Rapid Structured Review Using Machine Learning

    Dec 1, 2023, 00:00

  • PCR252 Early Steps Towards a Huntington's Disease Burden-of-Illness Model: Estimating Out-of-Pocket Costs for Patients Showing Clinical Symptoms

    Dec 1, 2023, 00:00

  • EE15 Cost-Effectiveness Analysis of Oral Semaglutide as the Second-Line and Third-Line Treatment for Type 2 Diabetes Patient

    Dec 1, 2023, 00:00

  • RWD48 Identification and Assessment of Real-World Oncology Data in China: A Data Landscaping Study

    Dec 1, 2023, 00:00

  • EE650 Incremental Costs of Tofacitinib Compared to Adalimumab and Ixekizumab for the Treatment of Active Ankylosing Spondylitis in Denmark

    Dec 1, 2023, 00:00

  • HTA213 Undertaking Studies to Inform Public Policy: Managing Data Collection to Ensure Data Quality in the EQ-5D-5L UK Valuation Through the Use of Independent Quality Control Assessments

    Dec 1, 2023, 00:00

  • EE133 Potential Budget Impact of Negative Pressure Wound Therapy (NPWT) Versus Conventional Wound Treatment (CWT) in Diabetic Foot Ulcers (DFU), Surgical Abdominal Wounds with Healing Impairment (SAWHI), and Trauma Wounds for Mexico

    Dec 1, 2023, 00:00

  • HTA19 Insights Into NICE Technology Appraisal Outcomes in Oncology

    Dec 1, 2023, 00:00

  • RWD99 Characterization of Comorbidities and Economic Burden in US Medicare Beneficiaries with Systemic Lupus Erythematosus with and without Lupus Nephritis

    Dec 1, 2023, 00:00

  • SA32 Exploring the Feasibility of Indication-Based Pricing in the Korea Healthcare System: A Survey Study

    Dec 1, 2023, 00:00

  • PCR264 Impact of Sodium Glucose Cotransporter-2 Inhibitors (SGLT2is) on Health-Related Quality of Life (HRQoL) Outcomes in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

    Dec 1, 2023, 00:00

  • HSD24 Digital Medical Services Delivered by Internet Hospitals via WeChat in China: A Qualitative Analytical Research

    Dec 1, 2023, 00:00

  • HSD107 Descriptive Analysis of Changes to Cardiovascular Healthcare Resource Use Recorded in Malaysian Real World Data from the Syntium Database before, during and after the COVID-19 Pandemic

    Dec 1, 2023, 00:00

  • CO78 Time to Diagnosis in Hypertrophic Cardiomyopathies and the Association With Adverse Outcomes Post-Diagnosis

    Dec 1, 2023, 00:00

  • SA43 Methods of Estimating Annualized Bleed Rates from Medical Records Among Patients with Hemophilia A

    Dec 1, 2023, 00:00

  • EE367 The Use of Genomic Tests for Early Breast Cancer in Finland Is Likely to be Cost-Effective at Common WTP Threshold

    Dec 1, 2023, 00:00

  • Patient-Centered Research

    Dec 1, 2023, 00:00

  • PCR95 Healthcare Resource Utilization for Adults Diagnosed with Moderate to Severe Atopic Dermatitis in Greece (APOLO STUDY)

    Dec 1, 2023, 00:00

  • PCR269 Detecting Changes in Relative Weighting of EQ-5D Dimensions and Levels with Sequential Analytical Hierarchy Process in Hong Kong Sar, China

    Dec 1, 2023, 00:00

  • CO14 Identification Use of Prognostic Variables (PVs)/Treatment Effect Modifiers (TEMs) in Indirect Treatment Comparisons (ITCs) By Systematic Literature Review (SLR): Case Study of Chimeric Antigen Receptor (CAR) T-Cell Therapies

    Dec 1, 2023, 00:00

  • EE162 Provider Budget Impact Model: Direct Transfer to Angiography Suite (DTAS) Without Stopping for CT Imaging for Patients With Acute Stroke in a German Setting

    Dec 1, 2023, 00:00

  • HTA69 Health-Related Quality of Life in the German Early Benefit Assessment—An Update

    Dec 1, 2023, 00:00

  • HPR98 Examining Reimbursement and Pricing Decisions of Oncohematological Medicines in Spain

    Dec 1, 2023, 00:00

  • HTA151 Subjective Well-Being and Mental Health During the COVID-19 Pandemic in Hungary

    Dec 1, 2023, 00:00

  • MSR71 Projecting the Potential Impact of Disease Modifying Therapy on the Future Health and Social Costs of Alzheimer’s Disease

    Dec 1, 2023, 00:00

  • EE682 Number Needed to Treat (NNT) Comparing Axicabtagene Ciloleucel and Best Supportive Care for Third Line Diffuse Large B-Cell Lymphoma in Brazil

    Dec 1, 2023, 00:00

  • PCR90 Hypoglossal Nerve Stimulation (HGNS) for Obstructive Sleep Apnea (OSA): A Systematic Review and Meta-Analysis of Patient-Reported Outcomes

    Dec 1, 2023, 00:00

  • EE73 Ocean (OP-103): Patients with Relapsed/Refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone or Pomalidomide Plus Dexamethasone - a Resource Utilization Analysis of Adverse Events Leading to Hospitalizations

    Dec 1, 2023, 00:00

  • EE619 A Cost-Utility Analysis of Low-Dose vs Standard-Dose Intravenous Alteplase in the Management of Acute Non-Lacunar Ischaemic Strokes: A Perspective From the NHS

    Dec 1, 2023, 00:00

  • RWD2 Catheter Ablation to Treat Cardiac Arrhythmia in Germany – Trends Based on German Hospital Data

    Dec 1, 2023, 00:00

  • CO97 Real-World Outcomes in Third-Line and Beyond (3L+) Small-Cell Lung Cancer (SCLC): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • EE754 Is the Paradigm Shifting? The REvalMED Pilot Program and Subsequent Integration of Economic Evaluations to Influence Pricing and Reimbursement Discussions in Spain

    Dec 1, 2023, 00:00

  • HTA156 Health Technology Assessment of Multiple Myeloma Therapies: Value Demonstration and Value Recognition Challenges

    Dec 1, 2023, 00:00

  • HPR208 Health Related Quality of Life Inequalities in Greece

    Dec 1, 2023, 00:00

  • EE597 Data on Human Population Mobility in Individual-Based Models of Infectious Disease Transmission: A Systematic Review

    Dec 1, 2023, 00:00

  • RWD57 Treatment Patterns and Cost of Care Among Patients With Metachromatic Leukodystrophy (MLD) in the US

    Dec 1, 2023, 00:00

  • EE640 The Impact of Blue-Light Emitting Device on the Loss of Productivity From COVID-19 in North Carolina

    Dec 1, 2023, 00:00

  • PCR13 The Burden of Informal Caregivers of People Diagnosed With Myasthenia Gravis

    Dec 1, 2023, 00:00

  • MSR94 Harnessing AI in Health Economics: Enhancing Efficiency, Accuracy, and Decision-Making

    Dec 1, 2023, 00:00

  • EE106 Artificial Intelligence (AI) Based Telemedicine for Cost-Effective Cataract Surgery Follow-up at NHS: An Economic Evaluation

    Dec 1, 2023, 00:00

  • PCR17 The Development of a Comprehensive Archive of Patient-Reported Outcome Measures (PROMS) for Clinical Research and Clinical Practice in Oncology

    Dec 1, 2023, 00:00

  • RWD76 Assessing the External Validity of Thin Database in Spain: A Reliable Source of Real-World Data for Observational Retrospective Research

    Dec 1, 2023, 00:00

  • HTA197 Increasing Patient Access in Scandinavia Through Outcome Based Agreements: Can the Spanish Model be Replicated?

    Dec 1, 2023, 00:00

  • HTA23 Reasons for a Negative Pharmaceutical Benefits Advisory Committee (PBAC) Review in Rare Diseases in Australia: A Comprehensive Analysis

    Dec 1, 2023, 00:00

  • HTA272 EUnetHTA's HTA Core Model®: A Critical Assessment and Future Outlook

    Dec 1, 2023, 00:00

  • EE601 Assessing the Barriers to Healthcare Resource Use (HRU) Data Collection and Offering Solutions to Support the Evidence Generation Process in LMICs

    Dec 1, 2023, 00:00

  • P26 Drug Utilization, Adherence, and Persistence in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada

    Dec 1, 2023, 00:00

  • EE144 Decision Modifiers Under Uncertainty: Comparison of Deterministic and Probabilistic Methods in Disease Severity Classification by NICE

    Dec 1, 2023, 00:00

  • P34 Health Technology Assessments of Digital Public Health Interventions in the Southeast Asia - A Systematic Scoping Review

    Dec 1, 2023, 00:00

  • EE595 Cost-Effectiveness of HPV Catch-up Vaccination Program in Women Aged 13-24 Years in Low-and Middle- Income Country

    Dec 1, 2023, 00:00

  • HTA314 A Review of Pediatric Medicines Assessed by NICE Between 2018 and 2023

    Dec 1, 2023, 00:00

  • RWD41 Utilization Patterns of Glucagon-like Peptide Receptor Agonists in Patients with Type 2 Diabetes in France and Italy

    Dec 1, 2023, 00:00

  • CO58 Patient Characteristics and Treatment Patterns in Patients with Mantle Cell Lymphoma in Spain: A Real-World, Cross-Sectional Study

    Dec 1, 2023, 00:00

  • HSD76 Assessing the Carbon Intensity Profile of an Immunization Program Against RSV in Infants in the United Kingdom to Show the Reduction in Emissions Versus Standard of Care

    Dec 1, 2023, 00:00

  • EPH256 Healthcare Resource Utilization and Related Cost Among Patients Hospitalized for Prurigo Nodularis: A Retrospective Cohort Study Using Italian Health Claims Data

    Dec 1, 2023, 00:00

  • EE268 Healthcare Costs and All-Cause Mortality Following a Hyperkalemia Event and Reduction of RAASi Therapy in Sweden

    Dec 1, 2023, 00:00

  • HTA264 Baseline Natural History Models in Network Meta-Analysis: Guidance Versus Implementation in National Health and Care Excellence (NICE) Appraisals

    Dec 1, 2023, 00:00

  • EE74 Cost-Effectiveness Analysis of LUNGFLAGTM Risk Prediction Model in the Selection of Individuals for Lung Cancer Screening in Spain

    Dec 1, 2023, 00:00

  • MSR66 Natural Language Processing to Support the Abstract Selection During Systematic Literature Review

    Dec 1, 2023, 00:00

  • PCR60 Shared Decision Making in Inflammatory Bowel Disease Clinical Practi What Are the Experiences, Barriers, and Opportunities According to Patients and Healthcare Professionals?

    Dec 1, 2023, 00:00

  • EE460 Intraarterial Thrombectomy for Acute Ischemic Stroke: Cost-Effective or Dominant across All Age Groups in Brazil

    Dec 1, 2023, 00:00

  • PCR255 Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions

    Dec 1, 2023, 00:00

  • PCR80 Patient Preferences for Stages II/III and Stage IV Melanoma Treatments in the UK

    Dec 1, 2023, 00:00

  • RWD119 A Decade of Alzheimer's Disease Management in Germany: The Increasing Impact of Specialists

    Dec 1, 2023, 00:00

  • HPR55 Reimbursement of High Priced One-Shot Treatments in Korea: KYMRIAH and ZOLGENSMA Case Study

    Dec 1, 2023, 00:00

  • HPR220 Assessment of the Relevance and Credibility of Indirect Treatment Comparisons (ITCs) to Help Inform Health Technology Assessment (HTA) and Reimbursement Decision-Making: Results of a 5-Country Payer Survey

    Dec 1, 2023, 00:00

  • EPH88 Human Papillomavirus (HPV) Vaccination Coverage Among French Adolescents: Papillon Study

    Dec 1, 2023, 00:00

  • CO116 The Significance of Serum Transaminases As Predictors of Mortality in Paraquat Poisoning: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • CO188 Mortality and Clinical Complications Among Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in France

    Dec 1, 2023, 00:00

  • EE492 Economic Analysis and Outcome Research on the Effectiveness of the Return to Work Program on Occupational Injury Cases for Workers with Disabilities

    Dec 1, 2023, 00:00

  • HTA230 Comparative Evaluation of the Performance of Two Value Attribution Frameworks When Applied to Combination Regimens in Oncology

    Dec 1, 2023, 00:00

  • HSD5 Knowledge, Attitude, and Practice of Pharmacy Professionals Against Dispensing Antibiotics Without Prescription in Ethiopia

    Dec 1, 2023, 00:00

  • PCR3 EQ-5D Utilities for Patients With Nonalcoholic Steatohepatitis (NASH): A Comparison of Historical Utilities to a Recent Real-World Multi-Country Patient Survey

    Dec 1, 2023, 00:00

  • RWD53 A Real-World Analysis of Treatment Patterns for First-Line Immunotherapies Among Danish Patients with Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression ≥50%

    Dec 1, 2023, 00:00

  • EE259 The Societal Cost of Age-Related Macular Degeneration and Diabetic Macular Edema: An Estimation Using a Pragmatic Literature Review

    Dec 1, 2023, 00:00

  • EE541 Cost-Effectiveness, Health-State Utility Values (HSUVs) and Cost and Resource Use (CRU) Associated with Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS): An Economic Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • MSR87 How Many Simulations of a Dynamic Transmission Model Are Enough to Estimate Uncertainty?

    Dec 1, 2023, 00:00

  • EE737 Cost-Effectiveness Models of Continuous Glucose Monitoring in Individuals With Type 1 Diabetes: A Systematic Review on Methodology and Quality

    Dec 1, 2023, 00:00

  • EE25 Cost-Effectiveness Analysis of S-Adenosylmethionine for the Treatment of Intrahepatic Cholestasis in China

    Dec 1, 2023, 00:00

  • EPH246 Landscape of Diffuse Large B-Cell Lymphoma (DLBCL) in Brazilian Public Healthcare System (SUS)

    Dec 1, 2023, 00:00

  • EPH33 Postpartum Hemorrhage: A Look into Colombia's Health System

    Dec 1, 2023, 00:00

  • CO38 Real-World Comparative COVID-19 Vaccine Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 Among Immunocompromised Adults in the US

    Dec 1, 2023, 00:00

  • PCR6 Impact of Perianal Fistulas on Crohn’s Disease Patients

    Dec 1, 2023, 00:00

  • EPH249 Effects of Adolescent MenACWY and MenC Vaccination in Germany: A Modelling Study

    Dec 1, 2023, 00:00

  • MSR29 A Comparative Analysis of Missing Value Imputation Techniques: Parametric Imputation with eCDF (PIE) Vs Markov Chain Monte Carlo Imputation (MCMC)

    Dec 1, 2023, 00:00

  • EPH111 A Real-World Study of the Relationship between Lipoprotein(A) [Lp(A)] Concentrations and Atherosclerotic Cardiovascular Disease (ASCVD) Prognosis, Healthcare Resource Utilization and Medical Costs in Chinese Patients

    Dec 1, 2023, 00:00

  • EE671 Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment for Renal Cell Carcinoma Post-Nephrectomy in France

    Dec 1, 2023, 00:00

  • PCR199 Value-Based Healthcare in Severe Asthma: Development of an Outcome Standard Set Pilot Study in Portugal

    Dec 1, 2023, 00:00

  • EE161 Economic Burden Associated with Stroke: A Comparative Analysis of Post-Stroke Care Costs

    Dec 1, 2023, 00:00

  • EE761 The Impact of Differences in Patient Demographics on Assessment of Long-Term Cost-Effectiveness in Cohort Level Economic Models

    Dec 1, 2023, 00:00

  • EE127 CAR-T Cell Therapies' Pathway: Evolution of Management and of Costing Methodology in the French Cost-Effectiveness Analyses (CEA) Landscape

    Dec 1, 2023, 00:00

  • EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US

    Dec 1, 2023, 00:00

  • PCR104 Is It Worth the Risk? Challenges and Recommendations for Devising Attributes and Levels for Safety-Related Attributes in Patient Preference Studies

    Dec 1, 2023, 00:00

  • HTA153 Did OS Immaturity Preclude from Receiving a Positive Recommendation: Review of Recent Oncology NICE/TA?

    Dec 1, 2023, 00:00

  • EE319 Update to the Macrovascular Submodels of the IQVIA Core Diabetes Model

    Dec 1, 2023, 00:00

  • EPH112 Prevalence, Incidence, and Patient Characteristics of Valvular Heart Disease Using the National Database of Health Insurance Claims in Japan

    Dec 1, 2023, 00:00

  • EPH197 An Integrated Modelling Methodology for Estimating Global, Regional, and Country-Specific Incidence and Prevalence of Tay-Sachs Disease at the Subtype Level

    Dec 1, 2023, 00:00

  • EE160 Healthcare Expenditure for Treatment of Hypertension and Hypertensive Complications in Japan: A Claims Data Analysis

    Dec 1, 2023, 00:00

  • EE365 Discrepancies Between Actual Costs and Reimbursement Tariffs for Breast Cancer Radiotherapy in Indonesia: A Hospital-Based Retrospective Study

    Dec 1, 2023, 00:00

  • EE291 Budget Impact Analysis of Mrna-1273 (Spikevax) in Patients with COVID-19 in Bulgaria

    Dec 1, 2023, 00:00

  • EPH177 The Impact of COVID-19 on National Mortality: Population-Based Interrupted Time Series Study in South Korea

    Dec 1, 2023, 00:00

  • HTA101 Mapping Opportunities in the Access Landscape for a New Rare Disease Treatment Option in Multiple EU Countries

    Dec 1, 2023, 00:00

  • HPR29 Evolution of the Utilization of the Aifa 5% Fund for Orphan Drugs and Rare Diseases

    Dec 1, 2023, 00:00

  • EE528 Analysis of Non-Pharmacological Cost Savings Derived from the Use of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Breast Cancer in Spain

    Dec 1, 2023, 00:00

  • PT1 A Comparison of the UK and Australian Interim Value Sets for the Weight-Specific Adolescent Instrument for Economic Evaluation (WAItE)

    Dec 1, 2023, 00:00

  • HTA233 Transportability of Overall Survival Estimates from US to UK Populations Receiving First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EE719 Systematic Literature Review for Monetary Costs Data in Hemophilia

    Dec 1, 2023, 00:00

  • EE337 Cost-Effectiveness of Nirmatrelvir/Ritonavir in High-Risk Swedish Adults Including Post-Acute COVID Syndrome (PACS) From a Societal Perspective

    Dec 1, 2023, 00:00

  • EE686 Cost Effectiveness of Ruxolitinib for Treatment of Steroid Refractory Acute Graft Versus Host Disease in Patients >12 Years of Age from a Singapore Healthcare System Perspective

    Dec 1, 2023, 00:00

  • PCR109 Patient Associations’ Members’ Perceptions of Level and Importance of Participation in Health Technology Assessment in Greece

    Dec 1, 2023, 00:00

  • MSR54 COVID-19: Do All Patients Who Meet the EMA High-Risk Definition Receive Prescription?

    Dec 1, 2023, 00:00

  • HTA84 Is Our Evidence Enough? A Review of G-BA's Ongoing Evidentiary Requirements in the Oncology Space

    Dec 1, 2023, 00:00

  • HTA273 Managed Access Agreements in the UK: A Detailed Analysis of NICE's Utilization and Impact on Access

    Dec 1, 2023, 00:00

  • HTA194 Do Health Technology Assessment (HTA) Bodies Recommend the Conduct and Submission of Artificial Intelligence-Based Literature Reviews (AILRS)?

    Dec 1, 2023, 00:00

  • MSR23 EQ-5D-5L Valuation Studies: Do the Effects of Dimensional Health Problems Interact with Each Other?

    Dec 1, 2023, 00:00

  • EPH267 A Quinquennial Review of the WHO’s Global Call for Action to Eliminate Cervical Cancer - an Indian Perspective

    Dec 1, 2023, 00:00

  • PCR202 Atoderma: Clinical and Economic Burden of Moderate to Severe Atopic Dermatitis in the Czech Republic

    Dec 1, 2023, 00:00

  • CO176 Treatment Approvals in Oncology and Relationship with Improvement in 5-Year Relative Survival for Cancer Patients in Europe

    Dec 1, 2023, 00:00

  • MT45 Digital Health Applications in the General Practitioner Context of Care: An Empirical Analysis of Patient Acceptance

    Dec 1, 2023, 00:00

  • EE453 Projecting the Economic Benefits of the Elective Recovery Plan in England

    Dec 1, 2023, 00:00

  • EE212 Understanding Service Use for Melanoma in the UK National Health Servi An Expert Elicitation Exercise Using a New Method for Eliciting Proportions

    Dec 1, 2023, 00:00

  • EE382 Burden and Economic Impact of Vaccine-Preventable Cancer Mortality in Europe

    Dec 1, 2023, 00:00

  • EE336 Cost-Effectiveness Analysis of Isavuconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis in Jordan

    Dec 1, 2023, 00:00

  • EE318 Cost-Effectiveness Analysis for Soliqua in the Treatment of T2DM in Turkiye

    Dec 1, 2023, 00:00

  • HTA164 Implementing Combination Treatment Cost-Effectiveness Solutions Beyond the Legal Challenges – What Else Needs to be in Place?

    Dec 1, 2023, 00:00

  • MSR46 Breaking Through Limitations: Enhanced Systematic Literature Reviews With Large Language Models

    Dec 1, 2023, 00:00

  • RWD66 Characterization of the Variation of Opioid Prescription in 15 Dutch Hospitals: A Real World Data Analysis

    Dec 1, 2023, 00:00

  • HTA218 Public Engagement and Its Influence on Health Technology Assessment Outcomes in Latin America

    Dec 1, 2023, 00:00

  • SA80 Priors on Between-Study Heterogeneity in Bayesian Meta-Analysis Models: A Simulation Study Using Hamiltonian Monte Carlo Sampling

    Dec 1, 2023, 00:00

  • PCR46 The Current Usage and Challenges of Goal Attainment Scaling in Clinical Settings

    Dec 1, 2023, 00:00

  • PCR22 Solidifying Usability Testing Guidelines for Ecoas From the Patient Perspective

    Dec 1, 2023, 00:00

  • HTA296 Applying Continual Stakeholder Engagement to Develop Multi-Criteria Decision Analysis (MCDA) for Health Technology Assessment in Major Depressive Disorder (MDD)

    Dec 1, 2023, 00:00

  • Faster Diagnosis and Treatment for Cancer: Assessing Patient Pathways Using a Panel Regression Analysis of the English National Cancer Registration Data [Editor's Choice]

    Dec 1, 2023, 00:00

  • EPH17 The Impact of COVID-19 Preventive Restrictions on the Development of Diseases of Despair: A Multi-Group Time Series Analysis

    Dec 1, 2023, 00:00

  • EPH49 The Short-Run and Long-Run Behavioral Effects of Vaccination Enforcement in Turkey

    Dec 1, 2023, 00:00

  • CO129 Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy (RWPC) for Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • HPR72 Regulation and Reality of the Market Access Process for Digital Health Applications (DiGA) in Germany

    Dec 1, 2023, 00:00

  • RWD56 Real World Data for Planning a New Organised Cancer Screening Programme in the Czech Republic: Example of Prostate Cancer Screening

    Dec 1, 2023, 00:00

  • CO153 Exploring the Impact of Healthcare Provider Stress on Patient Outcomes: A Review Protocol

    Dec 1, 2023, 00:00

  • RWD160 Time to Treatment Initiation and Patient Characteristics in Newly Diagnosed Multiple Myeloma Patients With and Without Transplant: Real-World Evidence Using Big Data From England

    Dec 1, 2023, 00:00

  • CO130 Q-TWiST Analysis Is Back in the Game in Oncology Clinical Trial Analysis: A Recent Trend

    Dec 1, 2023, 00:00

  • PCR121 Insights, Needs, and Perspectives From Patients, Caregivers, and Healthcare Professionals on Shared Decision Making in Duchenne Muscular Dystrophy: A Qualitative Study

    Dec 1, 2023, 00:00

  • HPR216 Multi-Stakeholder Perspectives on Interpretation, Challenges, and Ways Forward for the Unmet Medical Need Concept – Semi-Structured Interviews

    Dec 1, 2023, 00:00

  • HTA305 Multicriteria Decision Analysis (MCDA) to Elicit Criteria for CAR-T Cell Health Technology Assessment (HTA) in Brazilian Private Healthcare System

    Dec 1, 2023, 00:00

  • RWD176 Economic Results Generated By Optimizing a Parenteral Medication Application Process

    Dec 1, 2023, 00:00

  • PCR197 Quality of Life and Duchenne Muscular Dystrophy: Greek Translation of the Pediatric Quality of Life Inventory (PEDSQL)3.0 Duchenne Muscular Dystrophy Module

    Dec 1, 2023, 00:00

  • MT24 Digital Therapeutics (DTX): Market Access Challenges and Stakeholder Perspectives in Germany

    Dec 1, 2023, 00:00

  • EE313 Cost-Utility of Apixaban for Secondary Stroke Prevention in Brazil

    Dec 1, 2023, 00:00

  • MT44 Submission Process and Requirements of Nordic Health Technology Assessment Organisations for Medical Technologies: Results of an Online Survey

    Dec 1, 2023, 00:00

  • RWD85 A Systematic Literature Review on the Use of Real-World Evidence in NICE Technology Appraisals Indicated for Multiple Myeloma

    Dec 1, 2023, 00:00

  • CO10 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Psoriatic Arthritis

    Dec 1, 2023, 00:00

  • MT68 Digital Therapeutics (DTx) for Alzheimer's Disease, Dementia and Mild Cognitive Impairment: A Pragmatic Review of Clinical Evidence

    Dec 1, 2023, 00:00

  • EE577 Early Initiation of Guselkumab Increases Duration of Complete Remission (Psoriasis Area and Severity Index 100) in Patients With Moderate-to-Severe Psoriasis

    Dec 1, 2023, 00:00

  • HPR78 From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada

    Dec 1, 2023, 00:00

  • HPR41 Linking the Price of a Drug to Its Real-Life Performan A Solution for Financing Innovative Therapies in France?

    Dec 1, 2023, 00:00

  • RWD61 Inclusion of Productivity Losses and Gains in Cost-Effectiveness Analyses in Psoriasis: Preliminary Report of a Brazilian Association of Psoriasis (LATAM/LMIC)

    Dec 1, 2023, 00:00

  • EE137 Healthcare Resource Utilization and Estimated Costs in Adult Pneumococcal Disease in Peru: Results from a Panel of Experts

    Dec 1, 2023, 00:00

  • HTA77 Is Stedi Steady? an Exploration of the Uncertainties Underlying the Quantification of the Broader Value of Antibiotics

    Dec 1, 2023, 00:00

  • P19 Demographics of Patients and Societal Burden of Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Italy and Spain

    Dec 1, 2023, 00:00

  • PCR86 Estimating Health-Related Quality of Life in Fabry Disease for Patients Treated with Enzyme-Replacement Therapy in the BALANCE Randomized Controlled Trial

    Dec 1, 2023, 00:00

  • HTA132 Reporting Patient Preference Studies in Health Technology Assessment Submissions: Does It Make a Difference?

    Dec 1, 2023, 00:00

  • HPR167 Neutralizing Efficacy of Expired Snake Antivenoms: A Systematic Review of Preclinical Studies and Real-World Experience

    Dec 1, 2023, 00:00

  • EE249 Cost and Outcomes of Teduglutide in Adult Patients With Short Bowel Syndrome—Is the Combination With BSC Cost-Effective for the Society?

    Dec 1, 2023, 00:00

  • PCR239 Quality of Life (QOL) Instruments Used in Clinicaltrials.gov-Indexed Trials of Gene-Modified Cell Therapy (GMCT) in Patients With Multiple Myeloma (MM)

    Dec 1, 2023, 00:00

  • MSR108 Geographic Search Filters for Embase.Com Interfa An Analysis Utilizing Multiple Case Studies

    Dec 1, 2023, 00:00

  • HPR188 Orphan Drugs – How Will the New Proposed European Union (EU) Commission Pharmaceutical Regulation Impact Therapies for Rare Diseases?

    Dec 1, 2023, 00:00

  • EE234 Economic Analysis of the Pronto Study

    Dec 1, 2023, 00:00

  • HSD106 Analysis of Health Economic Evidence in Clinical Practice Guidelines Published in China Between 2017 and 2022: An Investigative Study

    Dec 1, 2023, 00:00

  • MSR44 Inflation, the Usual Suspect: Are Oncology Drugs Really Victims of the Macroeconomic Context?

    Dec 1, 2023, 00:00

  • OP28 Are Best Practice Methods for Expert Elicitation Being Applied in NICE Highly Specialized Technology (HST) Submissions? A Review and Evaluation

    Dec 1, 2023, 00:00

  • HSD53 Effect of COVID-19 Pandemic on the Delivery Time and the Point of Re-Order of Pharmaceuticals at the Logistics Services in a Governmental Hospital in Riyadh Saudi Arabia

    Dec 1, 2023, 00:00

  • HTA125 Assessment Outcome by HTA Agency Archetype: Five-Year Review for 20 European Countries

    Dec 1, 2023, 00:00

  • PT47 High-Volume Hospitals Experience Fewer Postoperative Complications After Neonatal Surgery: Analyses of the National Clinical Database Pediatric Surgical Registry in Japan

    Dec 1, 2023, 00:00

  • PCR26 Testing the Psychometric Properties of Several Euroqol Instruments for Measuring the Impact of COVID-19 in a Large Sample of Chinese Children and Their Parent Carers

    Dec 1, 2023, 00:00

  • EE170 A Cost-Effectiveness Analysis, with Public Healthcare Payers’ Perspective, of Oral Semaglutide Versus Luseogliflozin Hydrate for Patients with Type 2 Diabetes Mellitus in a Japanese Clinical Setting

    Dec 1, 2023, 00:00

  • CO189 Comparative Efficacy of Voclosporin in Combination With Mycophenolate Mofetil Versus Other Treatments in Active Lupus Nephritis: Systematic Review and Network Meta-Analysis

    Dec 1, 2023, 00:00

  • CO61 Isatuximab in Multiple Myeloma: Safety and Effectiveness

    Dec 1, 2023, 00:00

  • PCR42 Humanistic Burden of Paroxysmal Nocturnal Hemoglobinuria from the Patient Perspective: Results from a Cross-Sectional Study

    Dec 1, 2023, 00:00

  • MSR151 Causal Machine Learning for Assessing Pneumococcal Vaccine Effectiveness: Innovations in Real-World Data Analysis and Confounding Pathway Adjustment

    Dec 1, 2023, 00:00

  • MSR126 AutoCriteria: Advancing Clinical Trial Study With AI-Powered Eligibility Criteria Extraction

    Dec 1, 2023, 00:00

  • A Longitudinal Evaluation of the Preferences of Patients With Advanced Cancer for Quality of Life and Survival in Malaysia: A Discrete Choice Experiment

    Dec 1, 2023, 00:00

  • HPR148 Bio-Hybrid Medicinal Products: Widening Access or Product Differentiation?

    Dec 1, 2023, 00:00

  • EE427 Health Economic Decision Models Used in the Cost-Effectiveness Analyses of Innovative Products Submitted to the French National Authority for Health (HAS)

    Dec 1, 2023, 00:00

  • PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

    Dec 1, 2023, 00:00

  • P55 Prevalence and Predictors of Primary Non-Adherence to Medications Prescribed in Primary Care

    Dec 1, 2023, 00:00

  • HSD86 Economic Attributes of Caregiver Burden Among Schizophrenia Patients: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • MT7 Barriers and Facilitators for the Use of Point of Care Diagnostics in Patients With Respiratory Tract Infections in Outpatient Care Related to the Peri-Launch Phase

    Dec 1, 2023, 00:00

  • P4 Testing SimPy, a Library for Patient-Level Simulations in Python: An Application to Resource Management in Healthcare Systems

    Dec 1, 2023, 00:00

  • EPH236 Suicidal Behavior in Patients with Chronic Pain: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • MSR88 Validation of a Programmed Probability Score Using the Screening Tool, Sympro to Assist Selection of Studies in Systematic Literature Reviews

    Dec 1, 2023, 00:00

  • RWD13 Treatment Pathways and Outcomes of Advanced Ovarian Cancer Patients Who Are Underrepresented in Trials

    Dec 1, 2023, 00:00

  • HPR159 Emerging Trends Shaping the Healthcare Ecosystem in the Middle East and North Africa Region

    Dec 1, 2023, 00:00

  • EE517 Cost-Effectiveness Analysis of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Greece

    Dec 1, 2023, 00:00

  • EE134 Pharmacoeconomic Evaluation of National Immunization Program Realisation in Algeria

    Dec 1, 2023, 00:00

  • EE13 Using Sensor-Based Glucose Monitors Dominates Self-Monitoring of Blood Glucose for Adults with Type 1 Diabetes in the Danish Healthcare Setting

    Dec 1, 2023, 00:00

  • EE706 Impact of Valoctocogene Roxaparvovec on the Economic Burden of Adults with Severe Hemophilia A Managed with Prophylaxis in the United States

    Dec 1, 2023, 00:00

  • PCR132 Correlation Between Quality of Life (QoL) of Patients Treated With Nivolumab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M SCCHN) and Their Caregivers

    Dec 1, 2023, 00:00

  • EE355 Pre-Progression Health State Utility Values From the TALAPRO-2 Clinical Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With HRR Mutations

    Dec 1, 2023, 00:00

  • HSD127 Impact of the COVID-19 Pandemic on Frequency of Surgeries in Germany Based on Hospital Data

    Dec 1, 2023, 00:00

  • EE641 Socioeconomic Status and Economic Burden of Pertussis in Adults: Post-Hoc Analyses of a Retrospective Database Study in England

    Dec 1, 2023, 00:00

  • EPH13 RSV Hospitalizations’ Burden in New-Born Patients and Potential Impact of Maternal Vaccination: A French Analysis

    Dec 1, 2023, 00:00

  • MSR139 Performance of Different Survival Models for Extrapolation of Immature OS Data for 2L+ NSCLC Therapies

    Dec 1, 2023, 00:00

  • EPH153 Clinical Characterization and Healthcare Resource Utilization in Adrenoleukodystrophy: A Nationwide Retrospective Cohort Using Swedish National Registries

    Dec 1, 2023, 00:00

  • MT38 Identifying High Cost and High Mortality Genetic Disease in the NICU

    Dec 1, 2023, 00:00

  • HTA162 Canadian HTA and Early-Phase Evidence in Oncology: Current Trends and the Path Ahead

    Dec 1, 2023, 00:00

  • EPH213 Hepatitis B Virus (HBV) and Human Papilloma Virus (HPV) Related Cancers Elimination Impact on Treatment Patterns (HELP-France) in France

    Dec 1, 2023, 00:00

  • EE723 Budget Impact of New Potassium-Lowering Therapies in the Treatment of Chronic Hyperkalemia: A Saudi Experience

    Dec 1, 2023, 00:00

  • HTA28 The Use of Expert Opinions, Patient, and Carer Perspectives and Real-World Evidence in Orphan Disease Submissions Differs for Health Technology Assessment Agencies Across the World

    Dec 1, 2023, 00:00

  • PCR32 Patient Preference for Paroxysmal Nocturnal Haemoglobinuria Treatments: Analysis From the Q-Methodology of Treatment Attributes

    Dec 1, 2023, 00:00

  • MT17 Cost and Resource Use Outcomes for Left Atrial Appendage Occlusion Patients Contraindicated to Transesophageal Echocardiography

    Dec 1, 2023, 00:00

  • HPR151 New Proposed European Commission Pharmaceutical Regulation – Potential Changes and Impact on Biosimilars

    Dec 1, 2023, 00:00

  • CO40 Non-Communicable Diseases Prevention in India: A Review of Suitable Instruments for Surveillance and a General Overview of Cultural, Behavioral Practices and Risk Factors for the Adult Population

    Dec 1, 2023, 00:00

  • RWD64 A Nationwide Population-Based Study of Herbal Medicine for the Treatment of Functional Dyspepsia

    Dec 1, 2023, 00:00

  • EE204 Saving Lives through Early Access: Exploring the Impact of a Managed Access Agreement in Adjuvant EGFRm NSCLC

    Dec 1, 2023, 00:00

  • HPR87 A Comparative Analysis of Market Access Processes Between Ukraine and Germany

    Dec 1, 2023, 00:00

  • SA69 Impact of COVID-19 on Health Care Resource Utilization and Costs in Patients With Chronic Obstructive Pulmonary Disease and Asthma in the United States (2018–2022): A Population-Based Study

    Dec 1, 2023, 00:00

  • HTA90 Quality of Clinical Evidence Submitted to a National HTA Agency in Ireland: 10 Years of Drugs for Oncology

    Dec 1, 2023, 00:00

  • PT33 Cost-Effectiveness of Pembrolizumab Plus Chemotherapy, With or Without Bevacizumab for the First-Line Treatment of PD-L1-Positive Patients With Persistent, Recurrent, or Metastatic Cervical Cancer in France

    Dec 1, 2023, 00:00

  • EE708 Cost-Effectiveness of Umeclidinium/Vilanterol (UMEC/VI) Versus Aclidinium/Formoterol (ACL/FOR) in Patients with COPD in the United Kingdom

    Dec 1, 2023, 00:00

  • HTA96 Carer Burden: Is HTA Helping or Harming the Gender Health Gap?

    Dec 1, 2023, 00:00

  • EE8 Еconomic Evaluation of Intravascular Ultrasound (IVUS) for Imaging in Patients with Coronary Artery Disease in Bulgaria

    Dec 1, 2023, 00:00

  • EE37 Method Matters: Cost-Minimization Versus Cost-Effectiveness Frameworks in Assessing Opioid Use Disorder Treatments

    Dec 1, 2023, 00:00

  • HTA120 Trends in Medical Device Reimbursement Decisions in South Korea: A Novel and Comprehensive Analysis

    Dec 1, 2023, 00:00

  • EPH25 Impact of Cancer Deaths on Years of Life and Productivity Losses in Japan in 2019

    Dec 1, 2023, 00:00

  • EE579 Cost Consequences of Using Clevidipine in Neurological Emergencies from the Perspective of a US Hospital

    Dec 1, 2023, 00:00

  • PCR134 Listening and Learning from the Voices of Patients with Myelodysplastic Syndromes and Their Caregivers: A Comprehensive Social Media Analysis Using Machine Learning and Natural Language Processing-Based Algorithms

    Dec 1, 2023, 00:00

  • HTA17 Comparison of Methods for Modelling the Cost-Effectiveness of Atezolizumab as an Adjuvant Treatment in Stage II-IIIA Non-Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • MSR59 Does Interval Time-Trade-Off Reduce Satisfying Effects and Inconsistencies in Valuation Studies?

    Dec 1, 2023, 00:00

  • RWD129 Cost Effectiveness of Onasemnogene Abeparvovec in Infants with Presymptomatic Spinal Muscular Atrophy in Italy

    Dec 1, 2023, 00:00

  • MT2 Description of Portal Hypertension Treatment by Transjugular Intrahepatic Portosystemic Shunt: A French National Hospital Database Analysis

    Dec 1, 2023, 00:00

  • Adherence to Treatment, Patients' Preferences, and Drug Use across Multiple Diseases

    Dec 1, 2023, 00:00

  • EE402 Cost Effectiveness Analysis of Levonorgestrel Vs Etonorgestrel in Contraception from the Mexican Context

    Dec 1, 2023, 00:00

  • PCR64 EQ-5D Utility Scores in Patients With Clinically Suspect Arthralgia (CSA): Differences Between Progressors and Non-Progressors

    Dec 1, 2023, 00:00

  • EE304 Estimating Health Related Quality of Life Effects in Vitiligo: Mapping EQ-5D-5L Utilities from Vitiligo Specific Scales, Re-Pigmentation Measures Using Data from the HI-Light Trial

    Dec 1, 2023, 00:00

  • PCR9 Rise of Undiagnosed Major Depressive Disorder Post-COVID-19 Pandemic in Europe

    Dec 1, 2023, 00:00

  • PCR232 Psychometric Properties of a Patient Reported Outcome Measure (PROM) Evaluating Patient Autonomy in Multiple Sclerosis (MS)

    Dec 1, 2023, 00:00

  • MSR72 The Impact of Life Expectancy Exclusion Criteria on Survival Curve Extrapolation

    Dec 1, 2023, 00:00

  • HPR199 To Operationalize the VBHC in the Medical Device Area – An Italian Experience

    Dec 1, 2023, 00:00

  • HTA300 How Fast Will the EU HTA Child Grow? Estimation of the Number of Procedures in the First Years of Implementation

    Dec 1, 2023, 00:00

  • CO65 Modelled Impact of Nirsevimab for All Infants in the Prevention of Respiratory Syncytial Virus (RSV): Related Hospitalizations and Its Predicted Cost to the Brazilian Public Healthcare System

    Dec 1, 2023, 00:00

  • PCR73 Sensitivity of EQ-5D to Assess Health-Related Quality of Life (HRQoL) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): KarMMa-3 Case Study Exploring EQ-5D Mapped from Disease-Specific Instruments

    Dec 1, 2023, 00:00

  • EE197 Cost-Effectiveness Analysis of Spinal Cord Stimulation in Sweden

    Dec 1, 2023, 00:00

  • HTA279 Retrospective Analysis of the French Early Access Experience Following the 2021 Reform

    Dec 1, 2023, 00:00

  • SA8 The Use of Care Pathway Analysis to Inform Health Economic Models and Evidence Generation Requirements: Practical Applications and Examples from Two Projects

    Dec 1, 2023, 00:00

  • MSR6 Application of the Atlas Algorithm to Identify the Carboplatin+Gemcitabine Regimen in Patients with Metastatic Triple-Negative Breast Cancer (MTNBC) through the French Nationwide Hospital Discharge Database (PMSI)

    Dec 1, 2023, 00:00

  • EE310 Botulinum Toxin Type a for the Treatment of Patients with Post-Stroke Focal Spasticity in Thailand: A Cost-Utility Analysis

    Dec 1, 2023, 00:00

  • EPH34 Knowledge on HPV and Vaccination Among Undergraduates in Vojvodina

    Dec 1, 2023, 00:00

  • PCR82 Hierarchical Clustering of Rare Diseases Based on Functional Impacts to Support the Identification of Potential Patient-Centered Outcomes Measures for Rare Diseases Research

    Dec 1, 2023, 00:00

  • EE654 Occupational Impact of Tardive Dyskinesia: A Cross-Sectional, International Survey Assessing the Perceptions and Experiences of Patients With TD and Physicians Who Treat TD

    Dec 1, 2023, 00:00

  • EE117 Cost-Effectiveness of Empagliflozin in Patients Affected By Chronic Kidney Disease in Italy

    Dec 1, 2023, 00:00

  • EPH85 Clinical Burden of GM2 Gangliosidoses in the United States (US): A Retrospective Observational Cohort Study Using Electronic Health Records (EHR)

    Dec 1, 2023, 00:00

  • HTA3 Health Technology Assessment Requirements: Sensitive to Bacteriophage Products or Too Resistant to Change?

    Dec 1, 2023, 00:00

  • EE633 Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease

    Dec 1, 2023, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18 (current)
  • 19
  • 20
  • »